US 8835402
Compound and method for treating myotonic dystrophy
granted A61PA61P21/00
Quick answer
US patent 8835402 (Compound and method for treating myotonic dystrophy) held by Sarepta Therapeutics, Inc. expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Sep 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61P, A61P21/00